Attached files

file filename
EX-31.1 - EXHIBIT 31.1 - BIOLARGO, INC.ex31-1.htm
EX-32.1 - EXHIBIT 32.1 - BIOLARGO, INC.ex32-1.htm
EX-21.1 - EXHIBIT 21.1 - BIOLARGO, INC.ex21-1.htm
EX-31.2 - EXHIBIT 31.2 - BIOLARGO, INC.ex31-2.htm
10-K - FORM 10-K - BIOLARGO, INC.blgo20151231_10k.htm

Exhibit 23.1

 

 

 

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

 

We consent to the incorporation by reference in the Registration Statements of BioLargo, Inc. on Form S-8 (File Nos. 333-153193, 333-113443, 333-103479, 333-102226, and 333-97839) of our report dated March 30, 2016, appearing in the Annual Report on Form 10-K of BioLargo, Inc. for the year ended December 31, 2015.

 

Our report dated March 30, 2016 contains an explanatory paragraph that states the Company has suffered recurring losses, negative cash flows from operations and has limited capital resources. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

 

 

/s/ HASKELL & WHITE LLP

 

Irvine, California

March 30, 2016